Clinical Trial Update: Early Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH) [Phase 2]

View source ↗

Summary

Phase 2 trial update on early treatment of borderline pulmonary arterial hypertension associated with systemic sclerosis (SSc-APAH); study completed with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Systemic Sclerosis

Snippet

Sponsor: Heidelberg University | Conditions: Systemic Sclerosis, Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-04-30